7085 related articles for article (PubMed ID: 2732751)
1. Toxicity of coumarin (1,2-benzopyrone) on human peripheral blood mononuclear cells and human and murine bone marrow progenitor stem cells.
Gallicchio VS; Hulette BC; Harmon C; Marshall ME
J Biol Response Mod; 1989 Apr; 8(2):116-21. PubMed ID: 2732751
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of coumarin (1,2 benzopyrone) and endotoxin in the induction of human interleukin-1.
Stuhlmeier K; Theyer G; Baumgartner G; Zlabinger GJ
Clin Exp Immunol; 1991 May; 84(2):317-23. PubMed ID: 2025958
[TBL] [Abstract][Full Text] [Related]
3. Effect of L-phenylalanine methyl ester on the colony formation of hematopoietic progenitor cells from human bone marrow.
Chau WK; Law P
Int J Cell Cloning; 1991 May; 9(3):211-9. PubMed ID: 2061621
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX.
Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
Drug Chem Toxicol; 1998 Feb; 21(1):15-26. PubMed ID: 9530527
[TBL] [Abstract][Full Text] [Related]
5. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-leucyl-L-leucine methyl ester on human marrow and protection of progenitor cells by IL-1.
Rosenfeld CS
Int J Cell Cloning; 1992 Jul; 10(4):249-53. PubMed ID: 1645032
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin.
Marshall ME; Mohler JL; Edmonds K; Williams B; Butler K; Ryles M; Weiss L; Urban D; Bueschen A; Markiewicz M
J Cancer Res Clin Oncol; 1994; 120 Suppl():S39-42. PubMed ID: 8132703
[TBL] [Abstract][Full Text] [Related]
9. Coumarin (1,2-benzopyrone) enhances DR and DQ antigen expressions by peripheral blood mononuclear cells in vitro.
Marshall ME; Rhoades JL; Mattingly C; Jennings CD
Mol Biother; 1991 Dec; 3(4):204-6. PubMed ID: 1768372
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro.
Marshall ME; Kervin K; Benefield C; Umerani A; Albainy-Jenei S; Zhao Q; Khazaeli MB
J Cancer Res Clin Oncol; 1994; 120 Suppl():S3-10. PubMed ID: 7510710
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes.
Ratanasavanh D; Lamiable D; Biour M; Guédès Y; Gersberg M; Leutenegger E; Riché C
Fundam Clin Pharmacol; 1996; 10(6):504-10. PubMed ID: 8985719
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hormone-refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
Marshall ME; Butler K; Hermansen D
Prostate; 1990; 17(2):95-9. PubMed ID: 2399194
[TBL] [Abstract][Full Text] [Related]
13. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
15. Effects of coumarin (1,2-benzopyrone) on lymphocyte, natural killer cell, and monocyte functions in vitro.
Marshall ME; Conley D; Hollingsworth P; Brown S; Thompson JS
J Biol Response Mod; 1989 Feb; 8(1):70-85. PubMed ID: 2921611
[TBL] [Abstract][Full Text] [Related]
16. Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies.
Marshall ME; Butler K; Fried A
Mol Biother; 1991 Sep; 3(3):170-8. PubMed ID: 1768368
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
18. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
Marshall ME; Riley LK; Rhoades J; Eichhorn T; Jennings CD; Cibull M; Thompson J
J Biol Response Mod; 1989 Feb; 8(1):62-9. PubMed ID: 2921610
[TBL] [Abstract][Full Text] [Related]
19. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
20. Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide.
Winton EF; Colenda KW
Exp Hematol; 1987 Jul; 15(6):710-4. PubMed ID: 3595769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
